Janet Gunzburg Sells 912 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) insider Janet Gunzburg sold 912 shares of the stock in a transaction dated Thursday, April 18th. The shares were sold at an average price of $22.85, for a total transaction of $20,839.20. Following the completion of the transaction, the insider now owns 35,220 shares of the company’s stock, valued at approximately $804,777. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Janet Gunzburg also recently made the following trade(s):

• On Wednesday, April 10th, Janet Gunzburg sold 2,768 shares of Phreesia stock. The stock was sold at an average price of $23.10, for a total transaction of $63,940.80.
• On Monday, April 8th, Janet Gunzburg sold 1,709 shares of Phreesia stock. The stock was sold at an average price of $22.62, for a total value of $38,657.58.
• On Tuesday, March 19th, Janet Gunzburg sold 2,817 shares of Phreesia stock. The stock was sold at an average price of $23.27, for a total value of $65,551.59.
• On Friday, February 9th, Janet Gunzburg sold 480 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total transaction of $13,440.00.
• On Thursday, February 1st, Janet Gunzburg sold 328 shares of Phreesia stock. The shares were sold at an average price of $25.99, for a total value of $8,524.72.

Phreesia Price Performance

Shares of PHR stock traded down $0.95 during mid-day trading on Friday, reaching $21.67. The company’s stock had a trading volume of 540,826 shares, compared to its average volume of 521,631. The firm’s 50-day moving average is $24.40 and its two-hundred day moving average is $21.26. The company has a market cap of $1.22 billion, a P/E ratio of -8.98 and a beta of 0.92. Phreesia, Inc. has a 1-year low of $12.05 and a 1-year high of $34.98. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.78 and a current ratio of 1.78.

Phreesia (NYSE:PHR) last posted its earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.58) by $0.02. The business had revenue of $95.00 million for the quarter, compared to analysts’ expectations of $93.52 million. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The firm’s revenue for the quarter was up 24.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.72) earnings per share. On average, research analysts predict that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Institutional Investors Weigh In On Phreesia

Several institutional investors and hedge funds have recently made changes to their positions in the company. Envestnet Asset Management Inc. lifted its holdings in Phreesia by 11.7% during the 1st quarter. Envestnet Asset Management Inc. now owns 9,692 shares of the company’s stock valued at $255,000 after purchasing an additional 1,015 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Phreesia by 160.9% during the first quarter. JPMorgan Chase & Co. now owns 85,546 shares of the company’s stock worth $2,254,000 after buying an additional 52,755 shares in the last quarter. Raymond James Financial Services Advisors Inc. raised its stake in shares of Phreesia by 20.7% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 8,427 shares of the company’s stock valued at $222,000 after acquiring an additional 1,447 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Phreesia by 0.9% in the 1st quarter. Bank of New York Mellon Corp now owns 219,598 shares of the company’s stock worth $5,788,000 after acquiring an additional 2,047 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its position in Phreesia by 27.6% during the 1st quarter. PNC Financial Services Group Inc. now owns 16,059 shares of the company’s stock worth $424,000 after acquiring an additional 3,473 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on PHR. Stephens reaffirmed an “overweight” rating and set a $28.00 target price on shares of Phreesia in a report on Friday, March 22nd. JMP Securities lifted their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Thursday, March 21st. Raymond James reissued an “outperform” rating and issued a $30.00 price target (up from $25.00) on shares of Phreesia in a research report on Friday, March 15th. Truist Financial initiated coverage on shares of Phreesia in a research report on Monday, February 26th. They set a “buy” rating and a $35.00 price objective on the stock. Finally, Barclays began coverage on shares of Phreesia in a research report on Wednesday, January 3rd. They issued an “overweight” rating and a $29.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $31.62.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.